You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
翰宇藥業(300199.SZ):擬增加翰宇創新產業大樓項目投資預算至8.55億元
格隆匯 12-23 21:14

格隆匯12月23日丨翰宇藥業(300199.SZ)公佈,20211222日,公司召開第五屆董事會第二次會議審議通過關於增加翰宇創新產業大樓項目投資預算的議案公司翰宇創新產業大樓項目原投資總額為6.5億元(含土地出讓金1.12億元),受各方因素的影響,根據後續投入的預測,董事會同意項目投資總金額增加至8.55億元(含土地出讓金1.12億元)

翰宇創新產業大樓項目系公司總部項目,位於深圳市龍華區觀盛四路7號,項目總用地面積為2.91萬平方米,總建築面積為11.99萬平方米,總承包單位為中國建築第八工程局有限公司。受觀瀾直升機場規劃的影響導致開工時間嚴重推遲,原計劃20177月開工,實際開工時間延後至20171110日。項目施工過程中,由於受到環保條件限制、土方外運、夜間無法施工及新冠疫情等外部因素影響,導致工期嚴重滯後1年零5個月。

目前本項目已進入規劃驗收階段及消防驗收階段。規劃驗收需國土部門簽訂延期合同,方可申請規劃驗收。消防系統現場調試及設備安裝中,預計本月組織消防驗收,20221季度之前驗收完畢

由於受到土方及基建材料的價格上漲,使得工程造價成本提高、項目建設金額增加,根據公司對翰宇創新產業大樓項目後續投入的預測,擬增加項目投資金額至8.55億元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account